Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Chlamydia-antigens-and-corresponding-DNA-fragments-and-uses-thereof

 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
The present invention relates to modified .beta.-chains of human hemoglobin having an oxygen ...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to polypeptides which are inhibitors of stem cell proliferation ("INPR...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to an inhibitor of stem cell proliferation (INPROL) characterized by ...


 Method of inhibiting angiogenesis using secreted proteins
Isolated Proteins Nucleotide and amino acid sequences, as presently determined, are reported below ...


 Balanced extraction system
The present invention is a device wherein matter to be extracted which contains various available ...


 Compounds for the treatment of hepatoma
What is claimed is: 1. The method of treatment of a living subject affected by hepatoma which ...


 5ht2 agonists for controlling IOP and treating glaucoma
1. A method for lowering or controlling intraocular pressure or treating glaucoma which comprises ...


 Insect resistant tomato and potato plants
We claim: 1. A chimeric gene capable of expressing in a plant cell comprising in sequence: (a) a ...


 Insect resistant plants
In accordance with one aspect of the present invention, there has been provided a method for ...


 Hybrid toxin
What is claimed is: 1. An insecticidal Bacillus thuringiensis hybrid toxin fragment, comprising: a) ...


 Chlamydia antigens and corresponding DNA fragments and uses thereof

Details
Inventors: Murdin, Andrew D.; Oomen, Raymond P.; Wang, Joe; Dunn, Pamela;
Assignee: Sanofi Pasteur Limited (Toronto, CA)
Primary Examiner: Graser; Jennifer E.
Assistant Examiner:
Attorney, Agent or Firm: Foley & Lardner LLP

The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding full-length, 5'-truncated or 3'-truncated 76 kDa protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 76 kDa protein gene in the host. Modifications are possible within the scope of this invention.

DETAILED DESCRIPTION The present invention provides purified and isolated polynucleotide molecules that encode the Chlamydia polypeptide designated 76 kDa protein (SEQ ID No: 1) which can be used in methods to prevent, treat, and diagnose Chlamydia infection.
In one form of the invention, the polynucleotide molecules are DNA that encode the polypeptide of SEQ ID No: 2.
Another form of the invention provides polypeptides corresponding to the isolated DNA molecules.
The amino acid sequence of the corresponding encoded polypeptide is shown as SEQ ID No: 2.
Another form of the invention provides truncated polypeptides corresponding to truncated DNA molecules.
In one embodiment, the truncated nucleotide and amino acid sequences are shown as SEQ ID Nos: 3 and 4 respectively.
In another embodiment, the truncated nucleotide and amino acid sequences are shown as SEQ ID Nos: 5 and 6 respectively.
Although Melgosa et al.
has reported cloning a 76 kDa protein from C.
pneumoniae, comparison of the gene sequence as reported by Melgosa et al.
to the published geneome sequence of C.
pneumoniae (http://chlamydia-www.
berkeley.
edu:4231/) reveals that, in fact, the genomic sequence in this region contains at least two open reading frames (ORFs), one in the 5' portion and one in the 3' portion.
The sequence reported in Melgosa et al.
is an in-frame fusion of the 5' end of the 5' ORF.
Thus, Melgosa's deduced protein is merely a 76 kDa fusion protein and not the 76 kDa protein observed by immunoblotting from various C.
pneumoniae isolates.
By contrast, the 76 kDa protein of the present invention is the full-length protein encoded by the 3'ORF in this region of the genome.
Notably, further analysis of the genome sequence (http://chlamydia-www.
berkeley.
edu:4231/) reveals at least one in-frame ATG upstream of the start codon of the 5' ORF, suggesting that the 5' ORF may form part of one or more larger ORFs.
Those skilled in the art will readily understand that the invention, having provided the polynucleotide sequences encoding the Chlamydia 76 kDa protein, also provides polynucleotides encoding fragments derived from such a polypeptide



Related patents
  Methods of treating inflammatory bowel disease using cholera toxin B subunit
What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with inflammatory bowel disease, comprising administering to the subject a ...
  Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
1. Hemoglobin derivative compatible with human and non-human animal plasma, comprising hemoglobin crosslinked by means of a crosslinker for proteins and a polyalkylene ...
  Anti hepatitis C virus antibody and uses thereof
OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means and methods for the treatment and prevention of HCV infection in humans....
  Chemical and/or biological decontamination system
OF THE INVENTION The present invention provides a composition that is effective in the decontamination of chemical agents and/or biological pathogens. The biological ...
  Immunostimulant bacterial membrane fractions in cancer treatment
The invention claimed is: 1. A method of stimulating an immune response and/or inducing an antitumor immune response in a mammal, including a human, in need thereof, ...
  Cloning and characterization of a human adenylyl cyclase
One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) polypeptide comprising the amino acid sequence of FIG. 1 (SEQ ID NO:2). A...
  Tumor antigen based on products of the tumor suppressor gene WT1
What is claimed is: 1. An isolated polypeptide which consists of at most 12 contiguous amino acid residues of a human WT1 protein, wherein the polypeptide comprises SEQ I...
  Methods of inhibiting GPR-9-6 function
The invention relates to an antibody (immunoglobulin) or functional fragment thereof (e.g., an antigen-binding fragment) which binds to a mammalian GPR-9-6 (GPR-9-6 is ...
  Method for cloning of a rare, specifically mutated cell
The invention is a new and improved method for reliably detecting the presence of a rare cell having a desired nucleotide mutation that was introduced by a sequence-...
  Vaccine against Gram-negative bacterial infections
OF THE PREFERRED EMBODIMENTS According to the present invention, a non-covalent, polyvalent complex between purified, detoxified LPS ("DLPS") derived from E. coli and ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved